{
  "ticker": "BIIB",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T07:50:06.454979",
  "count": 114,
  "transactions": [
    {
      "id": 7011,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-22",
      "transaction_shares": "262",
      "transaction_price": "221.23",
      "transaction_type": "S",
      "shares_after_transaction": "4886.0915"
    },
    {
      "id": 18042,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-22",
      "transaction_shares": "262",
      "transaction_price": "221.23",
      "transaction_type": "S",
      "shares_after_transaction": "4886.0915"
    },
    {
      "id": 31965,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-22",
      "transaction_shares": "262",
      "transaction_price": "221.23",
      "transaction_type": "S",
      "shares_after_transaction": "4886.0915"
    },
    {
      "id": 49814,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-22",
      "transaction_shares": "262",
      "transaction_price": "221.23",
      "transaction_type": "S",
      "shares_after_transaction": "4886.0915"
    },
    {
      "id": 890,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "914",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6191.7483"
    },
    {
      "id": 896,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1370",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10006"
    },
    {
      "id": 902,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3423",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "52506"
    },
    {
      "id": 904,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-16",
      "transaction_shares": "856",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9623.9895"
    },
    {
      "id": 905,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4568",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "20692"
    },
    {
      "id": 906,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3197",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14340.716"
    },
    {
      "id": 910,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-16",
      "transaction_shares": "819",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5335.0915"
    },
    {
      "id": 7009,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "914",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6191.7483"
    },
    {
      "id": 7016,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1370",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10006"
    },
    {
      "id": 7022,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3423",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "52506"
    },
    {
      "id": 7024,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-16",
      "transaction_shares": "856",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9623.9895"
    },
    {
      "id": 7025,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4568",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "20692"
    },
    {
      "id": 7026,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3197",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14340.716"
    },
    {
      "id": 7030,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-16",
      "transaction_shares": "819",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5335.0915"
    },
    {
      "id": 18040,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "914",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6191.7483"
    },
    {
      "id": 18047,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1370",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10006"
    },
    {
      "id": 18053,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3423",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "52506"
    },
    {
      "id": 18056,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-16",
      "transaction_shares": "856",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9623.9895"
    },
    {
      "id": 18057,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4568",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "20692"
    },
    {
      "id": 18058,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3197",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14340.716"
    },
    {
      "id": 18063,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-16",
      "transaction_shares": "819",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5335.0915"
    },
    {
      "id": 31962,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "914",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6191.7483"
    },
    {
      "id": 31970,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1370",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10006"
    },
    {
      "id": 31976,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3423",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "52506"
    },
    {
      "id": 31979,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-16",
      "transaction_shares": "856",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9623.9895"
    },
    {
      "id": 31980,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4568",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "20692"
    },
    {
      "id": 31981,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3197",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14340.716"
    },
    {
      "id": 31986,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-16",
      "transaction_shares": "819",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5335.0915"
    },
    {
      "id": 49811,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "914",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "6191.7483"
    },
    {
      "id": 49820,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1370",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10006"
    },
    {
      "id": 49827,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3423",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "52506"
    },
    {
      "id": 49832,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-16",
      "transaction_shares": "856",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9623.9895"
    },
    {
      "id": 49833,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4568",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "20692"
    },
    {
      "id": 49835,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3197",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14340.716"
    },
    {
      "id": 49841,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-16",
      "transaction_shares": "819",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5335.0915"
    },
    {
      "id": 899,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Rowinsky Eric K",
      "reporting_owner_cik": "0001318886",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-15",
      "transaction_shares": "455",
      "transaction_price": "222.54",
      "transaction_type": "P",
      "shares_after_transaction": "20629"
    },
    {
      "id": 7019,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Rowinsky Eric K",
      "reporting_owner_cik": "0001318886",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-15",
      "transaction_shares": "455",
      "transaction_price": "222.54",
      "transaction_type": "P",
      "shares_after_transaction": "20629"
    },
    {
      "id": 18050,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Rowinsky Eric K",
      "reporting_owner_cik": "0001318886",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-15",
      "transaction_shares": "455",
      "transaction_price": "222.54",
      "transaction_type": "P",
      "shares_after_transaction": "20629"
    },
    {
      "id": 31973,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Rowinsky Eric K",
      "reporting_owner_cik": "0001318886",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-15",
      "transaction_shares": "455",
      "transaction_price": "222.54",
      "transaction_type": "P",
      "shares_after_transaction": "20629"
    },
    {
      "id": 49824,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Rowinsky Eric K",
      "reporting_owner_cik": "0001318886",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-15",
      "transaction_shares": "455",
      "transaction_price": "222.54",
      "transaction_type": "P",
      "shares_after_transaction": "20629"
    },
    {
      "id": 881,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1515",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9081"
    },
    {
      "id": 891,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3257",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "17555"
    },
    {
      "id": 895,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1212",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5309.0915"
    },
    {
      "id": 898,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2272",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9528.9895"
    },
    {
      "id": 907,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2158",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11777.716"
    },
    {
      "id": 909,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2575",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "50021"
    },
    {
      "id": 913,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "833",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5522.7483"
    },
    {
      "id": 7000,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1515",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9081"
    },
    {
      "id": 7010,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3257",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "17555"
    },
    {
      "id": 7015,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1212",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5309.0915"
    },
    {
      "id": 7018,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2272",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9528.9895"
    },
    {
      "id": 7027,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2158",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11777.716"
    },
    {
      "id": 7029,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2575",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "50021"
    },
    {
      "id": 7033,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "833",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5522.7483"
    },
    {
      "id": 18031,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1515",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9081"
    },
    {
      "id": 18041,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3257",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "17555"
    },
    {
      "id": 18046,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1212",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5309.0915"
    },
    {
      "id": 18049,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2272",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9528.9895"
    },
    {
      "id": 18059,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2158",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11777.716"
    },
    {
      "id": 18062,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2575",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "50021"
    },
    {
      "id": 18066,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "833",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5522.7483"
    },
    {
      "id": 31953,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1515",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9081"
    },
    {
      "id": 31963,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3257",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "17555"
    },
    {
      "id": 31969,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1212",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5309.0915"
    },
    {
      "id": 31972,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2272",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9528.9895"
    },
    {
      "id": 31982,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2158",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11777.716"
    },
    {
      "id": 31985,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2575",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "50021"
    },
    {
      "id": 31989,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "833",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5522.7483"
    },
    {
      "id": 49800,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1515",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9081"
    },
    {
      "id": 49812,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3257",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "17555"
    },
    {
      "id": 49819,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1212",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5309.0915"
    },
    {
      "id": 49823,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2272",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9528.9895"
    },
    {
      "id": 49836,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2158",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "11777.716"
    },
    {
      "id": 49840,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2575",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "50021"
    },
    {
      "id": 49844,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "833",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5522.7483"
    },
    {
      "id": 884,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1635",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10117.716"
    },
    {
      "id": 885,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2101",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7894.9895"
    },
    {
      "id": 887,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "788",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4942.7483"
    },
    {
      "id": 894,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2190",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "48101"
    },
    {
      "id": 901,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2043",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "8187"
    },
    {
      "id": 912,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2335",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "15063"
    },
    {
      "id": 7003,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1635",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10117.716"
    },
    {
      "id": 7004,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2101",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7894.9895"
    },
    {
      "id": 7006,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "788",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4942.7483"
    },
    {
      "id": 7014,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2190",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "48101"
    },
    {
      "id": 7021,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2043",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "8187"
    },
    {
      "id": 7032,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2335",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "15063"
    },
    {
      "id": 18034,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1635",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10117.716"
    },
    {
      "id": 18035,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2101",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7894.9895"
    },
    {
      "id": 18037,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "788",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4942.7483"
    },
    {
      "id": 18045,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2190",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "48101"
    },
    {
      "id": 18052,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2043",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "8187"
    },
    {
      "id": 18065,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2335",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "15063"
    },
    {
      "id": 31956,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1635",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10117.716"
    },
    {
      "id": 31957,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2101",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7894.9895"
    },
    {
      "id": 31959,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "788",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4942.7483"
    },
    {
      "id": 31968,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2190",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "48101"
    },
    {
      "id": 31975,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2043",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "8187"
    },
    {
      "id": 31988,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2335",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "15063"
    },
    {
      "id": 49804,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2024-02-08",
      "transaction_shares": "1635",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10117.716"
    },
    {
      "id": 49805,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2101",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7894.9895"
    },
    {
      "id": 49808,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "788",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4942.7483"
    },
    {
      "id": 49817,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2190",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "48101"
    },
    {
      "id": 49826,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Global Product Strat.",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2043",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "8187"
    },
    {
      "id": 49843,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "MCDONNELL MICHAEL R",
      "reporting_owner_cik": "0001121897",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2335",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "15063"
    },
    {
      "id": 886,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-01",
      "transaction_shares": "1828",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5292.0915"
    },
    {
      "id": 7005,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-01",
      "transaction_shares": "1828",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5292.0915"
    },
    {
      "id": 18036,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-01",
      "transaction_shares": "1828",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5292.0915"
    },
    {
      "id": 31958,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-01",
      "transaction_shares": "1828",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5292.0915"
    },
    {
      "id": 49807,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Singhal Priya",
      "reporting_owner_cik": "0001769608",
      "reporting_owner_position": "Head of Development",
      "transaction_date": "2024-02-01",
      "transaction_shares": "1828",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5292.0915"
    }
  ]
}